港股異動 | 遠大住工(2163.HK)漲5.8% 獲券商看好
格隆匯9月15日丨遠大住工(2163.HK)股價持續拉昇,現報33.35港元,漲幅5.87%,最新總市值162.63億。華創證券研報指,新增推薦遠大住工,公司是全國規模最大的PC構件生產企業,全資工廠+聯合工廠的合計產能達680萬方,2019年收益口徑的市佔率為16.5%,全國第一,預計未來3-5年產能仍將保持高速擴張。公司PC構件業務的盈利能力在2019年邁入上升拐點,主要系生產線利用率同比大幅提升近30個百分點,隨着行業進入放量期,以及公司管理系統、生產系統的不斷完善,料未來產能利用率及管理效率將繼續提升,盈利能力也將隨之提高。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.